|
CHO
|
IC50 |
|
Inhibition of rat voltage-gated K channel 3.1 expressed in CHO cells by patch clamp assay
Inhibition of rat voltage-gated K channel 3.1 expressed in CHO cells by patch clamp assay
|
[PMID: 23121096]
|
|
CHO
|
IC50 |
|
Inhibition of rat voltage-gated K channel 3.1 expressed in CHO cells by patch clamp assay
Inhibition of rat voltage-gated K channel 3.1 expressed in CHO cells by patch clamp assay
|
[PMID: 23121096]
|
|
HEK293
|
IC50 |
2.5 1
Compound: fluoxetine
|
Displacement of [I125]RTI-55 from human SERT transfected in human HEK293 cells
Displacement of [I125]RTI-55 from human SERT transfected in human HEK293 cells
|
[PMID: 20034793]
|
|
HEK293
|
IC50 |
1020 1
Compound: Fluoxetine
|
Displacement of [3H]norepinephrine from human recombinant NET expressed in HEK293 cells by scintillation counting
Displacement of [3H]norepinephrine from human recombinant NET expressed in HEK293 cells by scintillation counting
|
[PMID: 19256502]
|
|
HEK293
|
EC50 |
|
Inhibition of human SERT-mediated serotonin reuptake in HEK293 cells
Inhibition of human SERT-mediated serotonin reuptake in HEK293 cells
|
[PMID: 21927645]
|
|
HEK293
|
IC50 |
150 1
Compound: Fluoxetine
|
Inhibition of human SERT expressed in HEK293 cells at incubated for 15 mins by neurotransmitter reuptake assay
Inhibition of human SERT expressed in HEK293 cells at incubated for 15 mins by neurotransmitter reuptake assay
|
[PMID: 25221656]
|
|
CHO
|
IC50 |
|
Inhibition of rat voltage-gated K channel 3.1 expressed in CHO cells by patch clamp assay
Inhibition of rat voltage-gated K channel 3.1 expressed in CHO cells by patch clamp assay
|
[PMID: 23121096]
|
|
HEK293
|
IC50 |
150 1
Compound: Fluoxetine
|
Inhibition of serotonin reuptake at human SERT expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay
Inhibition of serotonin reuptake at human SERT expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay
|
[PMID: 24974340]
|
|
HEK293
|
IC50 |
|
Inhibition of serotonin reuptake at human SERT expressed in HEK293 cells
Inhibition of serotonin reuptake at human SERT expressed in HEK293 cells
|
[PMID: 20724153]
|
|
HEK293
|
IC50 |
18400 1
Compound: Fluoxetine
|
Inhibition of human DAT expressed in HEK293 cells at incubated for 15 mins by neurotransmitter reuptake assay
Inhibition of human DAT expressed in HEK293 cells at incubated for 15 mins by neurotransmitter reuptake assay
|
[PMID: 25221656]
|
|
HEK293
|
IC50 |
5.2 1
Compound: Fluoxetine
|
Inhibition of [3H]serotonin reuptake at human SERT expressed in HEK293 cells by scintillation counting
Inhibition of [3H]serotonin reuptake at human SERT expressed in HEK293 cells by scintillation counting
|
[PMID: 21093273]
|
|
HEK293
|
IC50 |
18400 1
Compound: Fluoxetine
|
Inhibition of DA reuptake at human DAT expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay
Inhibition of DA reuptake at human DAT expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay
|
[PMID: 24974340]
|
|
HEK293
|
IC50 |
|
Inhibition of [3H]5HT from human recombinant SERT expressed in HEK293 cells
Inhibition of [3H]5HT from human recombinant SERT expressed in HEK293 cells
|
[PMID: 19014888]
|
|
HEK293
|
IC50 |
7.2 1
Compound: Fluoxetine, Prozac
|
Displacement of [3H]imipramin from human recombinant SERT over-expressed in HEK293 cells
Displacement of [3H]imipramin from human recombinant SERT over-expressed in HEK293 cells
|
[PMID: 24012181]
|
|
HEK293
|
IC50 |
19500 1
Compound: Fluoxetine
|
Displacement of [3H]dopamine from human recombinant DAT expressed in HEK293 cells by scintillation counting
Displacement of [3H]dopamine from human recombinant DAT expressed in HEK293 cells by scintillation counting
|
[PMID: 19256502]
|
|
HEK293
|
IC50 |
7.3 1
Compound: Fluoxetine
|
Displacement of [3H]serotonin from human recombinant SERT expressed in HEK293 cells by scintillation counting
Displacement of [3H]serotonin from human recombinant SERT expressed in HEK293 cells by scintillation counting
|
[PMID: 19256502]
|
|
HEK293
|
IC50 |
4410 1
Compound: Fluoxetine
|
Inhibition of human NET expressed in HEK293 cells at incubated for 15 mins by neurotransmitter reuptake assay
Inhibition of human NET expressed in HEK293 cells at incubated for 15 mins by neurotransmitter reuptake assay
|
[PMID: 25221656]
|
|
HEK293
|
IC50 |
4410 1
Compound: Fluoxetine
|
Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay
Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay
|
[PMID: 24974340]
|
|
HEK293
|
IC50 |
8.6 1
Compound: fluoxetine
|
Displacement of [3H]Paroxetine from human recombinant SERT expressed in HEK293 cells after 60 mins
Displacement of [3H]Paroxetine from human recombinant SERT expressed in HEK293 cells after 60 mins
|
[PMID: 23403082]
|
|
HEK293
|
EC50 |
|
Inhibition of human SERT-mediated serotonin reuptake in HEK293 cells
Inhibition of human SERT-mediated serotonin reuptake in HEK293 cells
|
[PMID: 21927645]
|
|
JAR
|
IC50 |
9.4 1
Compound: fluoxetine
|
Inhibition of [3H]hydroxytryptamine creatinine sulfate uptake at human SERT expressed in human JAR cells
Inhibition of [3H]hydroxytryptamine creatinine sulfate uptake at human SERT expressed in human JAR cells
|
[PMID: 19722525]
|
|
HEK293
|
IC50 |
5.2 1
Compound: Fluoxetine
|
Inhibition of [3H]serotonin reuptake at human SERT expressed in HEK293 cells by scintillation counting
Inhibition of [3H]serotonin reuptake at human SERT expressed in HEK293 cells by scintillation counting
|
[PMID: 21093273]
|
|
HEK293
|
IC50 |
7.3 1
Compound: Fluoxetine
|
Displacement of [3H]serotonin from human recombinant SERT expressed in HEK293 cells by scintillation counting
Displacement of [3H]serotonin from human recombinant SERT expressed in HEK293 cells by scintillation counting
|
[PMID: 19256502]
|
|
JAR
|
IC50 |
9.4 1
Compound: fluoxetine
|
Inhibition of 5HT uptake at human SERT expressed in human JAR cells
Inhibition of 5HT uptake at human SERT expressed in human JAR cells
|
[PMID: 18557608]
|
|
JAR
|
IC50 |
9.4 1
Compound: Fluoxetine
|
Inhibition of human SERT expressed in human JAR cells
Inhibition of human SERT expressed in human JAR cells
|
[PMID: 20378347]
|
|
HEK293
|
IC50 |
8.6 1
Compound: fluoxetine
|
Displacement of [3H]Paroxetine from human recombinant SERT expressed in HEK293 cells after 60 mins
Displacement of [3H]Paroxetine from human recombinant SERT expressed in HEK293 cells after 60 mins
|
[PMID: 23403082]
|
|
HEK293
|
IC50 |
1020 1
Compound: Fluoxetine
|
Inhibition of [3H]NE from human recombinant NET expressed in HEK293 cells
Inhibition of [3H]NE from human recombinant NET expressed in HEK293 cells
|
[PMID: 19014888]
|
|
JAR
|
IC50 |
9.4 1
Compound: Fluoxetine
|
Inhibition of human SERT expressed in JAR cells
Inhibition of human SERT expressed in JAR cells
|
[PMID: 19713106]
|
|
HeLa
|
IC50 |
10 3
Compound: 33; MMV001561
|
Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 48 hrs by resazurin dye based fluorescence assay
Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 48 hrs by resazurin dye based fluorescence assay
|
[PMID: 30647879]
|
|
HEK293
|
IC50 |
1020 1
Compound: Fluoxetine
|
Displacement of [3H]norepinephrine from human recombinant NET expressed in HEK293 cells by scintillation counting
Displacement of [3H]norepinephrine from human recombinant NET expressed in HEK293 cells by scintillation counting
|
[PMID: 19256502]
|
|
JAR
|
IC50 |
9.4 1
Compound: Fluoxetine
|
Inhibition of human SERT expressed in JAR cells assessed as serotonin uptake
Inhibition of human SERT expressed in JAR cells assessed as serotonin uptake
|
[PMID: 21916421]
|
|
JAR
|
IC50 |
32.4 1
Compound: fluoxetine
|
Inhibition concentration against [3H]5-HT uptake by human serotonin transporter in JAR cells
Inhibition concentration against [3H]5-HT uptake by human serotonin transporter in JAR cells
|
[PMID: 15239661]
|
|
HEK293
|
IC50 |
|
Inhibition of of human TREK1 expressed in HEK293 cells assessed as reduction in channel currents
Inhibition of of human TREK1 expressed in HEK293 cells assessed as reduction in channel currents
|
[PMID: 26588045]
|
|
JAR
|
IC50 |
9.4 1
Compound: Fluoxetine
|
Inhibition of serotonin uptake at human SERT expressed in human JAR cells
Inhibition of serotonin uptake at human SERT expressed in human JAR cells
|
[PMID: 20131864]
|
|
MDA-MB-231
|
IC50 |
|
Anticancer activity against human MDA-MB-231 cells assessed as cell growth inhibition incubated for 24 hrs by MTT assay
Anticancer activity against human MDA-MB-231 cells assessed as cell growth inhibition incubated for 24 hrs by MTT assay
|
[PMID: 33650861]
|
|
HEK293
|
IC50 |
150 1
Compound: Fluoxetine
|
Inhibition of serotonin reuptake at human SERT expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay
Inhibition of serotonin reuptake at human SERT expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay
|
[PMID: 24974340]
|
|
JAR
|
IC50 |
|
Inhibition of serotonin uptake at human SERT expressed in JAR cells
Inhibition of serotonin uptake at human SERT expressed in JAR cells
|
[PMID: 18951020]
|
|
MDA-MB-436
|
IC50 |
|
Anticancer activity against human MDA-MB-436 cells assessed as cell growth inhibition incubated for 24 hrs by MTT assay
Anticancer activity against human MDA-MB-436 cells assessed as cell growth inhibition incubated for 24 hrs by MTT assay
|
[PMID: 33650861]
|
|
HEK293
|
IC50 |
150 1
Compound: Fluoxetine
|
Inhibition of human SERT expressed in HEK293 cells at incubated for 15 mins by neurotransmitter reuptake assay
Inhibition of human SERT expressed in HEK293 cells at incubated for 15 mins by neurotransmitter reuptake assay
|
[PMID: 25221656]
|
|
JAR
|
IC50 |
9.4 1
Compound: fluoxetine
|
Inhibition of serotonin uptake at human SERT expressed in JAR cells
Inhibition of serotonin uptake at human SERT expressed in JAR cells
|
[PMID: 19632110]
|
|
RD
|
CC50 |
11.9 3
Compound: Fluoxetine
|
Cytotoxicity against human RD cells after 3 days by neutral red dye-based photometric method
Cytotoxicity against human RD cells after 3 days by neutral red dye-based photometric method
|
[PMID: 30912944]
|
|
HEK293
|
IC50 |
16 1
Compound: fluoxetine
|
Inhibition of [3H]5-HT uptake at 5HT transporter expressed in HEK293 cells
Inhibition of [3H]5-HT uptake at 5HT transporter expressed in HEK293 cells
|
[PMID: 16750359]
|
|
Ventricular myocyte
|
IC50 |
2.82 3
Compound: Fluoxetine
|
Inhibition of L-type calcium channel measured using whole-cell patch clamp in rat ventricular myocytes
Inhibition of L-type calcium channel measured using whole-cell patch clamp in rat ventricular myocytes
|
[PMID: 22761000]
|
|
HEK293
|
IC50 |
16 1
Compound: fluoxetine
|
Inhibition of [3H]5-HT reuptake at 5HT transporter in HEK293 cells
Inhibition of [3H]5-HT reuptake at 5HT transporter in HEK293 cells
|
[PMID: 16750363]
|
|
JAR
|
IC50 |
9.4 1
Compound: Fluoxetine
|
Inhibition of SERT-mediated serotonin uptake in human JAR cells
Inhibition of SERT-mediated serotonin uptake in human JAR cells
|
[PMID: 20462211]
|
|
JAR
|
IC50 |
|
Inhibition of serotonin uptake at human SERT expressed in human JAR cells
Inhibition of serotonin uptake at human SERT expressed in human JAR cells
|
[PMID: 19329313]
|
|
HEK293
|
IC50 |
18400 1
Compound: Fluoxetine
|
Inhibition of DA reuptake at human DAT expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay
Inhibition of DA reuptake at human DAT expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay
|
[PMID: 24974340]
|
|
JAR
|
IC50 |
|
Inhibition of serotonin uptake at human SERT expressed in JAR cells
Inhibition of serotonin uptake at human SERT expressed in JAR cells
|
[PMID: 18771916]
|
|
HEK293
|
IC50 |
18400 1
Compound: Fluoxetine
|
Inhibition of human DAT expressed in HEK293 cells at incubated for 15 mins by neurotransmitter reuptake assay
Inhibition of human DAT expressed in HEK293 cells at incubated for 15 mins by neurotransmitter reuptake assay
|
[PMID: 25221656]
|
|
MCF7
|
IC50 |
10 1
Compound: Fluoxetine
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth
|
[PMID: 32738968]
|
|
HEK293
|
IC50 |
19500 1
Compound: Fluoxetine
|
Inhibition of [3H]DA from human recombinant DAT expressed in HEK293 cells
Inhibition of [3H]DA from human recombinant DAT expressed in HEK293 cells
|
[PMID: 19014888]
|
|
HEK293
|
IC50 |
19500 1
Compound: Fluoxetine
|
Displacement of [3H]dopamine from human recombinant DAT expressed in HEK293 cells by scintillation counting
Displacement of [3H]dopamine from human recombinant DAT expressed in HEK293 cells by scintillation counting
|
[PMID: 19256502]
|
|
HEK293
|
IC50 |
|
Displacement of [3H] astemizole from human recombinant ERG channel expressed in HEK293 cells
Displacement of [3H] astemizole from human recombinant ERG channel expressed in HEK293 cells
|
[PMID: 20637635]
|
|
HEK293
|
IC50 |
|
Inhibition of dopamine uptake at human DAT expressed in HEK cells
Inhibition of dopamine uptake at human DAT expressed in HEK cells
|
[PMID: 18667309]
|
|
HEK293
|
IC50 |
2.5 1
Compound: fluoxetine
|
Displacement of [I125]RTI-55 from human SERT transfected in human HEK293 cells
Displacement of [I125]RTI-55 from human SERT transfected in human HEK293 cells
|
[PMID: 20034793]
|
|
HEK293
|
IC50 |
|
Inhibition of dopamine uptake at human DAT in human HEK293 cells
Inhibition of dopamine uptake at human DAT in human HEK293 cells
|
[PMID: 18550369]
|
|
HEK293
|
IC50 |
|
Inhibition of norepinephrine uptake at human NET in human HEK293 cells
Inhibition of norepinephrine uptake at human NET in human HEK293 cells
|
[PMID: 18550369]
|
|
HEK293
|
IC50 |
|
Inhibition of norepinephrine uptake at human NET expressed in HEK cells
Inhibition of norepinephrine uptake at human NET expressed in HEK cells
|
[PMID: 18667309]
|
|
HEK293
|
IC50 |
2000 1
Compound: Fluoxetine
|
Inhibition of norepinephrine uptake at human NET expressed in HEK cells
Inhibition of norepinephrine uptake at human NET expressed in HEK cells
|
[PMID: 18667309]
|
|
HEK293
|
IC50 |
|
Inhibition of norepinephrine uptake at human NET in human HEK293 cells
Inhibition of norepinephrine uptake at human NET in human HEK293 cells
|
[PMID: 18550369]
|
|
HEK293
|
IC50 |
|
Inhibition of serotonin reuptake at human SERT expressed in HEK293 cells
Inhibition of serotonin reuptake at human SERT expressed in HEK293 cells
|
[PMID: 20724153]
|
|
HEK293
|
IC50 |
|
Inhibition of of human TREK1 expressed in HEK293 cells assessed as reduction in channel currents
Inhibition of of human TREK1 expressed in HEK293 cells assessed as reduction in channel currents
|
[PMID: 26588045]
|
|
HEK293
|
IC50 |
|
Displacement of [3H] astemizole from human recombinant ERG channel expressed in HEK293 cells
Displacement of [3H] astemizole from human recombinant ERG channel expressed in HEK293 cells
|
[PMID: 20637635]
|
|
HEK293
|
IC50 |
4400 1
Compound: fluoxetine
|
Inhibition of DA transporter expressed in HEK293 cells
Inhibition of DA transporter expressed in HEK293 cells
|
[PMID: 16750359]
|
|
HEK293
|
IC50 |
16 1
Compound: fluoxetine
|
Inhibition of [3H]5-HT reuptake at 5HT transporter in HEK293 cells
Inhibition of [3H]5-HT reuptake at 5HT transporter in HEK293 cells
|
[PMID: 16750363]
|
|
HEK293
|
IC50 |
16 1
Compound: fluoxetine
|
Inhibition of [3H]5-HT uptake at 5HT transporter expressed in HEK293 cells
Inhibition of [3H]5-HT uptake at 5HT transporter expressed in HEK293 cells
|
[PMID: 16750359]
|
|
HEK293
|
IC50 |
4400 1
Compound: fluoxetine
|
Inhibition of [3H]DA reuptake at DA transporter in HEK293 cells
Inhibition of [3H]DA reuptake at DA transporter in HEK293 cells
|
[PMID: 16750363]
|
|
HeLa
|
IC50 |
10 3
Compound: 33; MMV001561
|
Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 48 hrs by resazurin dye based fluorescence assay
Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 48 hrs by resazurin dye based fluorescence assay
|
[PMID: 30647879]
|
|
HEK293
|
IC50 |
4410 1
Compound: Fluoxetine
|
Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay
Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay
|
[PMID: 24974340]
|
|
JAR
|
IC50 |
32.4 1
Compound: fluoxetine
|
Inhibition concentration against [3H]5-HT uptake by human serotonin transporter in JAR cells
Inhibition concentration against [3H]5-HT uptake by human serotonin transporter in JAR cells
|
[PMID: 15239661]
|
|
HEK293
|
IC50 |
4410 1
Compound: Fluoxetine
|
Inhibition of human NET expressed in HEK293 cells at incubated for 15 mins by neurotransmitter reuptake assay
Inhibition of human NET expressed in HEK293 cells at incubated for 15 mins by neurotransmitter reuptake assay
|
[PMID: 25221656]
|
|
K562
|
CC50 |
|
Cytotoxicity to reduce chronic myeloid leukemia K 562 cells
Cytotoxicity to reduce chronic myeloid leukemia K 562 cells
|
[PMID: 15267229]
|
|
HEK293
|
IC50 |
|
Inhibition of serotonin uptake at human SERT in human HEK293 cells
Inhibition of serotonin uptake at human SERT in human HEK293 cells
|
[PMID: 18550369]
|
|
JAR
|
IC50 |
39.4 1
Compound: fluoxetine
|
Inhibition of [3H]5-HT uptake at human 5-HT transporter expressed in Jar cells
Inhibition of [3H]5-HT uptake at human 5-HT transporter expressed in Jar cells
|
[PMID: 16854086]
|
|
HEK293
|
IC50 |
47 1
Compound: Fluoxetine
|
Inhibition of serotonin uptake at human SERT expressed in HEK cells
Inhibition of serotonin uptake at human SERT expressed in HEK cells
|
[PMID: 18667309]
|
|
JAR
|
IC50 |
39.4 1
Compound: fluoxetine
|
Inhibition of 5-HT transporter-mediated [3H]5HT uptake in human Jar cells
Inhibition of 5-HT transporter-mediated [3H]5HT uptake in human Jar cells
|
[PMID: 18834188]
|
|
HEK293
|
IC50 |
5.2 1
Compound: Fluoxetine
|
Inhibition of [3H]serotonin reuptake at human SERT expressed in HEK293 cells by scintillation counting
Inhibition of [3H]serotonin reuptake at human SERT expressed in HEK293 cells by scintillation counting
|
[PMID: 21093273]
|
|
HEK293
|
IC50 |
47 1
Compound: Fluoxetine
|
Inhibition of serotonin uptake at human SERT expressed in HEK cells
Inhibition of serotonin uptake at human SERT expressed in HEK cells
|
[PMID: 18667309]
|
|
HEK293
|
IC50 |
5200 1
Compound: fluoxetine
|
Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells
Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells
|
[PMID: 16750359]
|
|
HEK293
|
IC50 |
5200 1
Compound: fluoxetine
|
Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells
Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells
|
[PMID: 16750363]
|
|
HEK293
|
IC50 |
|
Inhibition of serotonin uptake at human SERT in human HEK293 cells
Inhibition of serotonin uptake at human SERT in human HEK293 cells
|
[PMID: 18550369]
|
|
MDA-MB-231
|
IC50 |
|
Anticancer activity against human MDA-MB-231 cells assessed as cell growth inhibition incubated for 24 hrs by MTT assay
Anticancer activity against human MDA-MB-231 cells assessed as cell growth inhibition incubated for 24 hrs by MTT assay
|
[PMID: 33650861]
|
|
HEK293
|
IC50 |
|
Inhibition of dopamine uptake at human DAT in human HEK293 cells
Inhibition of dopamine uptake at human DAT in human HEK293 cells
|
[PMID: 18550369]
|
|
MDA-MB-436
|
IC50 |
|
Anticancer activity against human MDA-MB-436 cells assessed as cell growth inhibition incubated for 24 hrs by MTT assay
Anticancer activity against human MDA-MB-436 cells assessed as cell growth inhibition incubated for 24 hrs by MTT assay
|
[PMID: 33650861]
|
|
HEK293
|
IC50 |
6000 1
Compound: Fluoxetine
|
Inhibition of dopamine uptake at human DAT expressed in HEK cells
Inhibition of dopamine uptake at human DAT expressed in HEK cells
|
[PMID: 18667309]
|
|
HEK293
|
IC50 |
|
Inhibition of [3H]5HT from human recombinant SERT expressed in HEK293 cells
Inhibition of [3H]5HT from human recombinant SERT expressed in HEK293 cells
|
[PMID: 19014888]
|
|
HEK293
|
IC50 |
150 1
Compound: Fluoxetine
|
Inhibition of human SERT expressed in HEK293 cells at incubated for 15 mins by neurotransmitter reuptake assay
Inhibition of human SERT expressed in HEK293 cells at incubated for 15 mins by neurotransmitter reuptake assay
|
[PMID: 25221656]
|
|
HEK293
|
IC50 |
150 1
Compound: Fluoxetine
|
Inhibition of serotonin reuptake at human SERT expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay
Inhibition of serotonin reuptake at human SERT expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay
|
[PMID: 24974340]
|
|
HEK293
|
IC50 |
7.2 1
Compound: Fluoxetine, Prozac
|
Displacement of [3H]imipramin from human recombinant SERT over-expressed in HEK293 cells
Displacement of [3H]imipramin from human recombinant SERT over-expressed in HEK293 cells
|
[PMID: 24012181]
|
|
MDCK
|
IC50 |
|
Inhibition of norepinephrine uptake at human NET expressed in MDCK cells
Inhibition of norepinephrine uptake at human NET expressed in MDCK cells
|
[PMID: 18771916]
|
|
HEK293
|
IC50 |
7.3 1
Compound: Fluoxetine
|
Displacement of [3H]serotonin from human recombinant SERT expressed in HEK293 cells by scintillation counting
Displacement of [3H]serotonin from human recombinant SERT expressed in HEK293 cells by scintillation counting
|
[PMID: 19256502]
|
|
HEK293
|
IC50 |
8.6 1
Compound: fluoxetine
|
Displacement of [3H]Paroxetine from human recombinant SERT expressed in HEK293 cells after 60 mins
Displacement of [3H]Paroxetine from human recombinant SERT expressed in HEK293 cells after 60 mins
|
[PMID: 23403082]
|
|
RD
|
CC50 |
11.9 3
Compound: Fluoxetine
|
Cytotoxicity against human RD cells after 3 days by neutral red dye-based photometric method
Cytotoxicity against human RD cells after 3 days by neutral red dye-based photometric method
|
[PMID: 30912944]
|
|
HEK293
|
IC50 |
1020 1
Compound: Fluoxetine
|
Displacement of [3H]norepinephrine from human recombinant NET expressed in HEK293 cells by scintillation counting
Displacement of [3H]norepinephrine from human recombinant NET expressed in HEK293 cells by scintillation counting
|
[PMID: 19256502]
|
|
HEK293
|
IC50 |
1020 1
Compound: Fluoxetine
|
Inhibition of [3H]NE from human recombinant NET expressed in HEK293 cells
Inhibition of [3H]NE from human recombinant NET expressed in HEK293 cells
|
[PMID: 19014888]
|
|
HEK293
|
IC50 |
4400 1
Compound: fluoxetine
|
Inhibition of [3H]DA reuptake at DA transporter in HEK293 cells
Inhibition of [3H]DA reuptake at DA transporter in HEK293 cells
|
[PMID: 16750363]
|
|
HEK293
|
IC50 |
4400 1
Compound: fluoxetine
|
Inhibition of DA transporter expressed in HEK293 cells
Inhibition of DA transporter expressed in HEK293 cells
|
[PMID: 16750359]
|
|
HEK293
|
IC50 |
4410 1
Compound: Fluoxetine
|
Inhibition of human NET expressed in HEK293 cells at incubated for 15 mins by neurotransmitter reuptake assay
Inhibition of human NET expressed in HEK293 cells at incubated for 15 mins by neurotransmitter reuptake assay
|
[PMID: 25221656]
|
|
HEK293
|
IC50 |
4410 1
Compound: Fluoxetine
|
Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay
Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay
|
[PMID: 24974340]
|
|
HEK293
|
IC50 |
5200 1
Compound: fluoxetine
|
Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells
Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells
|
[PMID: 16750363]
|
|
HEK293
|
IC50 |
5200 1
Compound: fluoxetine
|
Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells
Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells
|
[PMID: 16750359]
|
|
HEK293
|
IC50 |
18400 1
Compound: Fluoxetine
|
Inhibition of DA reuptake at human DAT expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay
Inhibition of DA reuptake at human DAT expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay
|
[PMID: 24974340]
|
|
HEK293
|
IC50 |
18400 1
Compound: Fluoxetine
|
Inhibition of human DAT expressed in HEK293 cells at incubated for 15 mins by neurotransmitter reuptake assay
Inhibition of human DAT expressed in HEK293 cells at incubated for 15 mins by neurotransmitter reuptake assay
|
[PMID: 25221656]
|
|
HEK293
|
IC50 |
19500 1
Compound: Fluoxetine
|
Displacement of [3H]dopamine from human recombinant DAT expressed in HEK293 cells by scintillation counting
Displacement of [3H]dopamine from human recombinant DAT expressed in HEK293 cells by scintillation counting
|
[PMID: 19256502]
|
|
HEK293
|
IC50 |
19500 1
Compound: Fluoxetine
|
Inhibition of [3H]DA from human recombinant DAT expressed in HEK293 cells
Inhibition of [3H]DA from human recombinant DAT expressed in HEK293 cells
|
[PMID: 19014888]
|
|
U-937
|
CC50 |
|
Cytotoxicity to reduce human histolytic lymphoma U937 cells
Cytotoxicity to reduce human histolytic lymphoma U937 cells
|
[PMID: 15267229]
|
|
Ventricular myocyte
|
IC50 |
2.82 3
Compound: Fluoxetine
|
Inhibition of L-type calcium channel measured using whole-cell patch clamp in rat ventricular myocytes
Inhibition of L-type calcium channel measured using whole-cell patch clamp in rat ventricular myocytes
|
[PMID: 22761000]
|
|
HeLa
|
IC50 |
10 3
Compound: 33; MMV001561
|
Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 48 hrs by resazurin dye based fluorescence assay
Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 48 hrs by resazurin dye based fluorescence assay
|
[PMID: 30647879]
|
|
JAR
|
IC50 |
|
Inhibition of serotonin uptake at human SERT expressed in JAR cells
Inhibition of serotonin uptake at human SERT expressed in JAR cells
|
[PMID: 18771916]
|
|
JAR
|
IC50 |
|
Inhibition of serotonin uptake at human SERT expressed in human JAR cells
Inhibition of serotonin uptake at human SERT expressed in human JAR cells
|
[PMID: 19329313]
|
|
JAR
|
IC50 |
32.4 1
Compound: fluoxetine
|
Inhibition concentration against [3H]5-HT uptake by human serotonin transporter in JAR cells
Inhibition concentration against [3H]5-HT uptake by human serotonin transporter in JAR cells
|
[PMID: 15239661]
|
|
JAR
|
IC50 |
39.4 1
Compound: fluoxetine
|
Inhibition of [3H]5-HT uptake at human 5-HT transporter expressed in Jar cells
Inhibition of [3H]5-HT uptake at human 5-HT transporter expressed in Jar cells
|
[PMID: 16854086]
|
|
JAR
|
IC50 |
39.4 1
Compound: fluoxetine
|
Inhibition of 5-HT transporter-mediated [3H]5HT uptake in human Jar cells
Inhibition of 5-HT transporter-mediated [3H]5HT uptake in human Jar cells
|
[PMID: 18834188]
|
|
JAR
|
IC50 |
|
Inhibition of serotonin uptake at human SERT expressed in JAR cells
Inhibition of serotonin uptake at human SERT expressed in JAR cells
|
[PMID: 18951020]
|
|
JAR
|
IC50 |
9.4 1
Compound: Fluoxetine
|
Inhibition of human SERT expressed in JAR cells
Inhibition of human SERT expressed in JAR cells
|
[PMID: 19713106]
|
|
JAR
|
IC50 |
9.4 1
Compound: Fluoxetine
|
Inhibition of serotonin uptake at human SERT expressed in human JAR cells
Inhibition of serotonin uptake at human SERT expressed in human JAR cells
|
[PMID: 20131864]
|
|
JAR
|
IC50 |
9.4 1
Compound: Fluoxetine
|
Inhibition of human SERT expressed in human JAR cells
Inhibition of human SERT expressed in human JAR cells
|
[PMID: 20378347]
|
|
JAR
|
IC50 |
9.4 1
Compound: Fluoxetine
|
Inhibition of SERT-mediated serotonin uptake in human JAR cells
Inhibition of SERT-mediated serotonin uptake in human JAR cells
|
[PMID: 20462211]
|
|
JAR
|
IC50 |
9.4 1
Compound: Fluoxetine
|
Inhibition of human SERT expressed in JAR cells assessed as serotonin uptake
Inhibition of human SERT expressed in JAR cells assessed as serotonin uptake
|
[PMID: 21916421]
|
|
JAR
|
IC50 |
9.4 1
Compound: fluoxetine
|
Inhibition of 5HT uptake at human SERT expressed in human JAR cells
Inhibition of 5HT uptake at human SERT expressed in human JAR cells
|
[PMID: 18557608]
|
|
JAR
|
IC50 |
9.4 1
Compound: fluoxetine
|
Inhibition of serotonin uptake at human SERT expressed in JAR cells
Inhibition of serotonin uptake at human SERT expressed in JAR cells
|
[PMID: 19632110]
|
|
JAR
|
IC50 |
9.4 1
Compound: fluoxetine
|
Inhibition of [3H]hydroxytryptamine creatinine sulfate uptake at human SERT expressed in human JAR cells
Inhibition of [3H]hydroxytryptamine creatinine sulfate uptake at human SERT expressed in human JAR cells
|
[PMID: 19722525]
|
|
K562
|
CC50 |
|
Cytotoxicity to reduce chronic myeloid leukemia K 562 cells
Cytotoxicity to reduce chronic myeloid leukemia K 562 cells
|
[PMID: 15267229]
|
|
MCF7
|
IC50 |
10 1
Compound: Fluoxetine
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth
|
[PMID: 32738968]
|
|
MDA-MB-231
|
IC50 |
|
Anticancer activity against human MDA-MB-231 cells assessed as cell growth inhibition incubated for 24 hrs by MTT assay
Anticancer activity against human MDA-MB-231 cells assessed as cell growth inhibition incubated for 24 hrs by MTT assay
|
[PMID: 33650861]
|
|
MDA-MB-436
|
IC50 |
|
Anticancer activity against human MDA-MB-436 cells assessed as cell growth inhibition incubated for 24 hrs by MTT assay
Anticancer activity against human MDA-MB-436 cells assessed as cell growth inhibition incubated for 24 hrs by MTT assay
|
[PMID: 33650861]
|
|
MDCK
|
IC50 |
|
Inhibition of norepinephrine uptake at human NET expressed in MDCK cells
Inhibition of norepinephrine uptake at human NET expressed in MDCK cells
|
[PMID: 18771916]
|
|
RD
|
CC50 |
11.9 3
Compound: Fluoxetine
|
Cytotoxicity against human RD cells after 3 days by neutral red dye-based photometric method
Cytotoxicity against human RD cells after 3 days by neutral red dye-based photometric method
|
[PMID: 30912944]
|
|
U-937
|
CC50 |
|
Cytotoxicity to reduce human histolytic lymphoma U937 cells
Cytotoxicity to reduce human histolytic lymphoma U937 cells
|
[PMID: 15267229]
|
|
Ventricular myocyte
|
IC50 |
2.82 3
Compound: Fluoxetine
|
Inhibition of L-type calcium channel measured using whole-cell patch clamp in rat ventricular myocytes
Inhibition of L-type calcium channel measured using whole-cell patch clamp in rat ventricular myocytes
|
[PMID: 22761000]
|